Tarsus Pharmaceuticals acquires Alkeus Pharmaceuticals (September 2026)
Tarsus Pharmaceuticals completed its acquisition of Alkeus Pharmaceuticals on 4 September 2026. Up-front consideration was $270M cash plus 2,908,692 Tarsus shares, with up to $350M in milestones (Tarsus 8-K).
Source: https://www.sec.gov/Archives/edgar/data/1819790/000181979026000066/tars-20260904.htm